QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
Log in
NASDAQ:SPNE

SeaSpine Stock Forecast, Price & News

$17.42
+0.27 (+1.57 %)
(As of 01/25/2021 12:00 AM ET)
Add
Compare
Today's Range
$16.88
Now: $17.42
$17.59
50-Day Range
$15.77
MA: $16.95
$18.33
52-Week Range
$4.02
Now: $17.42
$18.98
Volume143,715 shs
Average Volume109,108 shs
Market Capitalization$481.37 million
P/E RatioN/A
Dividend YieldN/A
Beta1.24
SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. The company provides orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. Its orthobiologics products include demineralized bone matrices (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. The company also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and DBM. Its spinal implant portfolio comprises products for spinal decompression, alignment, and stabilization that are used to facilitate fusion in degenerative, minimally invasive, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical regions of the spine. The company has development and licensing agreement with restor3d, Inc. to develop 3D-printed interbody devices. SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.
SeaSpine logo

MarketRank

Overall MarketRank

1.28 out of 5 stars

Medical Sector

713th out of 1,922 stocks

Surgical & Medical Instruments Industry

71st out of 168 stocks

Analyst Opinion: 1.4Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SPNE
CUSIPN/A
Phone760-727-8399
Employees386
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$159.08 million
Book Value$5.74 per share

Profitability

Net Income$-39,280,000.00

Miscellaneous

Market Cap$481.37 million
Next Earnings Date2/24/2021 (Estimated)
OptionableOptionable
$17.42
+0.27 (+1.57 %)
(As of 01/25/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SPNE News and Ratings via Email

Sign-up to receive the latest news and ratings for SPNE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











SeaSpine (NASDAQ:SPNE) Frequently Asked Questions

How has SeaSpine's stock price been impacted by Coronavirus (COVID-19)?

SeaSpine's stock was trading at $10.73 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SPNE stock has increased by 62.3% and is now trading at $17.42.
View which stocks have been most impacted by COVID-19
.

Is SeaSpine a buy right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SeaSpine in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" SeaSpine stock.
View analyst ratings for SeaSpine
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than SeaSpine?

Wall Street analysts have given SeaSpine a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but SeaSpine wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Keith Valentine's approval rating as SeaSpine's CEO?

23 employees have rated SeaSpine CEO Keith Valentine on Glassdoor.com. Keith Valentine has an approval rating of 79% among SeaSpine's employees.

When is SeaSpine's next earnings date?

SeaSpine is scheduled to release its next quarterly earnings announcement on Wednesday, February 24th 2021.
View our earnings forecast for SeaSpine
.

How were SeaSpine's earnings last quarter?

SeaSpine Holdings Co. (NASDAQ:SPNE) issued its quarterly earnings data on Saturday, November, 14th. The medical equipment provider reported ($0.24) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.31) by $0.07. The medical equipment provider had revenue of $43.21 million for the quarter, compared to analysts' expectations of $43.10 million. SeaSpine had a negative net margin of 27.32% and a negative trailing twelve-month return on equity of 24.38%.
View SeaSpine's earnings history
.

What guidance has SeaSpine issued on next quarter's earnings?

SeaSpine issued an update on its FY 2020 Pre-Market earnings guidance on Monday, January, 11th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $154.1-154.5 million, compared to the consensus revenue estimate of $155.18 million.

What price target have analysts set for SPNE?

6 brokerages have issued 12 month target prices for SeaSpine's stock. Their forecasts range from $10.00 to $23.00. On average, they anticipate SeaSpine's share price to reach $17.33 in the next year. This suggests that the stock has a possible downside of 0.5%.
View analysts' price targets for SeaSpine
or view Wall Street analyst' top-rated stocks.

Who are some of SeaSpine's key competitors?

What other stocks do shareholders of SeaSpine own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SeaSpine investors own include AbbVie (ABBV), Corbus Pharmaceuticals (CRBP), Gilead Sciences (GILD), Kura Oncology (KURA), Recro Pharma (REPH), Rigel Pharmaceuticals (RIGL), Spectrum Pharmaceuticals (SPPI), ViewRay (VRAY), Verastem (VSTM) and Akorn (AKRX).

Who are SeaSpine's key executives?

SeaSpine's management team includes the following people:
  • Mr. Keith C. Valentine, Pres, CEO & Director (Age 53, Pay $1.06M)
  • Mr. John J. Bostjancic, Sr. VP, CFO & Treasurer (Age 50, Pay $592.62k)
  • Mr. Tyler P. Lipschultz, Sr. VP of Orthobiologics & Bus. Devel. (Age 54, Pay $592.66k)
  • Carrie Mendivil, Head of Investor Relations
  • Mr. Patrick L. Keran, Sr. VP, Gen. Counsel & Sec. (Age 49)
  • Mr. John J. Winge, VP of Sales (Age 54)
  • Mr. Dennis L. Cirino, Sr. VP of Global Spinal Systems (Age 51)
  • Paul Benny, VP, Corp. Controller, Assistant Treasurer & Assistant Sec.

What is SeaSpine's stock symbol?

SeaSpine trades on the NASDAQ under the ticker symbol "SPNE."

Who are SeaSpine's major shareholders?

SeaSpine's stock is owned by many different institutional and retail investors. Top institutional investors include Paradigm Capital Management Inc. NY (1.72%). Company insiders that own SeaSpine stock include John B Henneman III, Keith Valentine, Richard E Caruso and Stuart Essig.
View institutional ownership trends for SeaSpine
.

Which major investors are buying SeaSpine stock?

SPNE stock was acquired by a variety of institutional investors in the last quarter, including Paradigm Capital Management Inc. NY.
View insider buying and selling activity for SeaSpine
or or view top insider-buying stocks.

How do I buy shares of SeaSpine?

Shares of SPNE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is SeaSpine's stock price today?

One share of SPNE stock can currently be purchased for approximately $17.42.

How big of a company is SeaSpine?

SeaSpine has a market capitalization of $481.37 million and generates $159.08 million in revenue each year. The medical equipment provider earns $-39,280,000.00 in net income (profit) each year or ($2.07) on an earnings per share basis. SeaSpine employs 386 workers across the globe.

What is SeaSpine's official website?

The official website for SeaSpine is www.seaspine.com.

How can I contact SeaSpine?

SeaSpine's mailing address is 5770 ARMADA DRIVE, CARLSBAD CA, 92008. The medical equipment provider can be reached via phone at 760-727-8399 or via email at [email protected]

This page was last updated on 1/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.